Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan

NCT00888576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 441

Last updated 2012-02-08

No results posted yet for this study

Summary

The purpose of this study is to develop a registry with safety and efficacy data on the use of etanercept in clinical practice in Taiwan.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00888576 on ClinicalTrials.gov